Shuyi Chen

Institute of Life Science, Jiyang College of Zhejiang A&F University, Zhuji, 311800, China
Author    Correspondence author
International Journal of Molecular Medical Science, 2024, Vol. 14, No. 1   doi: 10.5376/ijmms.2024.14.0009
Received: 01 Mar., 2024    Accepted: 02 Apr., 2024    Published: 12 Apr., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Chen S.Y., 2024, Optimizing drug therapy using genomic information: a pathway to personalized medicine, International Journal of Molecular Medical Science, 14(1): 61-68 (doi: 10.5376/ijmms.2024.14.0009)

This article explores the utilization of genomic information to optimize drug treatment, aiming to achieve personalized healthcare. As an emerging medical model, personalized healthcare aims to develop precise treatment plans based on patients' genomic information, thereby enhancing treatment outcomes and minimizing side effects. Initially, the importance of genomic information in personalized healthcare is introduced, encompassing its application in precise drug development and preventive medicine. The article then analyzes successful cases and challenges in the practical application of personalized healthcare, discussing technical limitations and cost issues in acquiring and analyzing Genomic data. Furthermore, ethical, privacy, and regulatory considerations in personalized healthcare are explored, along with suggestions and strategies to promote its development. Additionally, the future trends of genomic information in optimizing drug treatment and personalized healthcare are predicted, emphasizing the significance of interdisciplinary collaboration and technological innovation. Through comprehensive analysis and outlook, this article aims to provide beneficial insights and directions for the advancement of personalized healthcare.

Genomic information; Drug therapy; Personalized medicine; Drug development